The current issue contains an update on the results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial. After a median followβup period of 47 months, there remains an advantage in terms of diseaseβfree survival (DFS) for patients treated with anastrozole compared with patients treated w
β¦ LIBER β¦
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
β Scribed by Neckers, L.; Workman, P.
- Book ID
- 115516609
- Publisher
- American Association for Cancer Research
- Year
- 2012
- Tongue
- English
- Weight
- 820 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1078-0432
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Adjuvant aromatase inhibitors : Are we t
β
Gini F. Fleming
π
Article
π
2003
π
John Wiley and Sons
π
English
β 50 KB
FLT3 Inhibitors in AML: Are We There Yet
β
Sudhindra, Akshay; Smith, Catherine Choy
π
Article
π
2014
π
Current Science Inc.
π
English
β 289 KB
Are We There Yet?
β
John H. Edmonson
π
Article
π
2000
π
Elsevier Science
π
English
β 64 KB
Are we there yet?
β
McIntyre R. Louthan
π
Article
π
2006
π
Springer US
π
English
β 224 KB
β
Levithan, David
π
Fiction
π
2005
π
Random House LLC
π
English
β 177 KB
Sixteen-year-old Elijah is completely mellow and his 23-year-old brother Danny is completely not, so itβs no wonder they can barely tolerate one another. So what better way to repair their broken relationship than to trick them into taking a trip to Italy together? Soon, though, their parentsβ perfe
Are we there yet?
β
Merrick, William C
π
Article
π
2007
π
Nature Publishing Group
π
English
β 243 KB